Latest Content

Lauren Yerkes, founder of POST SWIM, discusses the jarring shift to breast cancer survivorship and the daily practice of reclaiming body confidence.

Columnist Linda Cohen explores the emotional toll of aging with lymphoma, the pressure of cosmetic trends, and finding beauty in enduring love.

The ATOMIC Trial shows how adding immunotherapy to chemotherapy may reduce recurrence risk and improve outcomes in stage III dMMR colon cancer.

The National Ovarian Cancer Coalition (NOCC) delivers free meals to ovarian cancer patients, easing treatment burdens and supporting caregivers nationwide.

Immunotherapy boosts the immune system to fight cancer but may cause skin side effects; early reporting helps manage symptoms and keep treatment on track.

Researchers identified gut microbiome markers that predict melanoma return after surgery, allowing doctors to personalize immunotherapy for patients.

Caroline Taylor discusses how disparities in access and resources affect diagnosis, treatment, and survival for patients globally.

Rezetapopt showed a 44.4% response rate and durable responses over 8 months in ovarian cancer with p53 Y220C mutation, with mostly mild side effects.

A colon cancer survivor shares how practicing daily gratitude and journaling helped her find peace, healing and the strength to build a vibrant life.

Dr. Thomas Flaig discusses new therapies, biomarkers and evolving care strategies in an interview with CURE.

After a sudden collapse, a resilient cancer survivor faces a new health crisis. Through faith, PT and grit, she overcomes despair to walk again.

Dr. Sunil Dutta discusses treatment approaches and managing side effects in esophageal cancer, including nutrition and patient support strategies.

The phase 3 LITESPARK-012 trial did not improve survival in advanced kidney cancer, highlighting ongoing need for better first-line treatments.